Skip to main content

Table 2 Diabetes management of insured adults with diagnosed type 2 diabetes

From: Type 2 diabetes detection and management among insured adults

Treatment metrics Total insured Commercial Medicare Medicaid
Annual glucose testing
 % receiving A1c 82% 80% 86% 64%
 % receiving FPG 12% 10% 14% 15%
 % receiving OGTT 0.6% 1.1% 0.2% 0.8%
Other recommended testing
 % receiving cholesterol test 76% 75% 81% 58%
 % receiving eye exam NA 33% 57% NA
 % receiving urinary albumin test 50% 45% 55% 43%
Medication to treat diabetesa
 % receiving diabetes medication 77% 82% 73% 75%
 Receiving diabetes medication 12,990,000 5,930,000 5,860,000 1,200,000
  Receiving metformin 46% 53% 40% 46%
  Receiving insulin 23% 21% 23% 29%
 Not receiving diabetes medication 3,900,000 1,290,000 2,220,000 390,000
Receiving other medications
 ACE inhibitors and ARBsb 63% 60% 67% 57%
 Other anti-hypertensives (e.g., diuretics) 47% 31% 62% 43%
 Statins 58% 55% 64% 46%
 % with hypertension 80% 72% 91% 61%
 % with hyperlipidemia 76% 75% 83% 43%
  1. Notes: aIncludes insulin, non-insulin injectables, or oral antidiabetic agents
  2. b ACE Angiotensin-converting enzyme inhibitors, ARB Angiotensin II receptor blockers